Abingdon Health PLC (GB:ABDX) has released an update.
Abingdon Health PLC has announced the appointment of Zeus Capital Limited as its new Nominated Adviser and Broker, effective immediately. This strategic change comes as a result of Zeus Capital’s acquisition of WH Ireland’s Capital Markets Division. Abingdon Health assures stakeholders that the transition is overseen by Chris Yates, the CEO.
For further insights into GB:ABDX stock, check out TipRanks’ Stock Analysis page.
